Bryan Troxell, Ph.D., is a Principal Scientist in the Quality Control and Analytical Development group at StrideBio. Prior to joining StrideBio, Dr. Troxell was a member of the Biotechnology group at Alcami Corporation, where he performed analytical testing of active pharmaceutical ingredients and drug products to serve the needs of clients within the pharmaceutical industry. This work was conducted under cGMP conditions for all phases of drug development (pre-clinical/R&D through phase III). Dr. Troxell received his Ph.D. in Microbiology from North Carolina State University and completed postdoctoral work at Indiana University School of Medicine and North Carolina State University.
Bryan Troxell, Ph.D.
PRINCIPAL SCIENTIST, QUALITY CONTROL